Related Experiment Video

Updated: May 28, 2026

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Deubiquitinases in cancer: new functions and therapeutic options

J M Fraile1, V Quesada, D Rodríguez

  • 1Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.

Oncogene
|October 15, 2011
PubMed

Insights

Deubiquitinases (DUBs) are crucial enzymes regulating protein stability and cell functions. Targeting DUBs offers a promising strategy for developing novel anticancer drugs by interfering with tumor growth mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Deubiquitinases (DUBs) are essential enzymes in the ubiquitin system, crucial for protein homeostasis and signaling pathways.
  • The human genome encodes at least 98 DUBs, categorized into 6 families, highlighting their diverse and specific roles.
  • Dysfunctional DUBs are implicated in various diseases, notably cancer, where they can act as oncogenes or tumor suppressors.

Purpose of the Study:

  • To explore the fundamental roles of DUBs in cellular processes and their connection to cancer.
  • To investigate the potential of targeting DUB activity for novel anticancer therapeutic strategies.
  • To leverage current knowledge of DUB regulation for developing new molecular therapies.

Main Methods:

  • Review of existing literature on DUBs, ubiquitin system, and cancer biology.
  • Analysis of DUBs' roles in protein turnover, activation, and localization.
  • Examination of DUBs' functions as oncogenes or tumor suppressors in tumor development.

Main Results:

  • DUBs are critical for cell homeostasis, protein stability, and signaling pathways.
  • Altered DUB activity is linked to cancer development, with some DUBs acting as oncogenes or tumor suppressors.
  • Tumor growth in several cancers depends on the normal activity of specific DUBs.

Conclusions:

  • Pharmacological targeting of DUB activity presents a viable strategy for novel anticancer drug discovery.
  • Further understanding of DUB functions and regulatory mechanisms is key to expanding molecular therapies for cancer.
  • DUB-targeting strategies hold significant potential for advancing cancer treatment options.

More Related Videos

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples09:45

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Published on: May 10, 2015

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...